Filing Details

Accession Number:
0001493152-21-030594
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-06 16:58:32
Reporting Period:
2021-12-02
Accepted Time:
2021-12-06 16:58:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1817004 Ezfill Holdings Inc EZFL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1124852 Jack Levine C/O Ezfill Holdings Inc.
2125 Biscayne Blvd, #309
Miami FL 33137
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-02 20,263 $2.25 94,026 No 4 P Direct
Common Stock Acquisiton 2021-12-02 254 $2.24 94,280 No 4 P Direct
Common Stock Acquisiton 2021-12-02 1,523 $2.28 95,803 No 4 P Direct
Common Stock Acquisiton 2021-12-03 18,000 $2.18 113,803 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 186,010 Indirect Cameo Life Sciences Investments LLC
Footnotes
  1. The 20,263 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.
  2. The 254 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.
  3. The 1,523 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.
  4. The 18,000 shares the Reporting Person purchased on December 3, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife.
  5. Jack Levine is the Manager of Cameo Life Sciences Investments LLC and beneficially owns 186,010 shares of common stock, which are held by Cameo Life Sciences Investments, LLC.